Top

Published in:

01-04-2015

Ultrasound elastography: liver

Authors: Manish Dhyani, Arash Anvari, Anthony E. Samir

Published in: Abdominal Radiology | Issue 4/2015

Abstract

Ultrasound elastography, also termed sonoelastography, is being used increasingly in clinical practice to aid the diagnosis and management of diffuse liver disease. Elastography has been shown to be capable of differentiating advanced and early-stage liver fibrosis, and consequently a major application in clinical liver care includes progression to cirrhosis risk stratification through (1) assessment of liver fibrosis stage in HCV and HBV patients, (2) distinguishing non-alcoholic steatohepatitis from simple steatosis in non-alcoholic fatty liver disease patients, and (3) prognostic evaluation of liver disease is autoimmune liver disease. In addition, elastographic characterization of focal liver lesions and evaluation of clinically significant portal hypertension have the potential to be clinically useful and are areas of active clinical research.

Younossi ZM, Stepanova M, Afendy M, et al. (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524–530 (e1– quiz e60). doi:10.1016/j.cgh.2011.03.020 PubMed

Murray CJL, Abraham J, Ali MK, et al. (2013) The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310:591–608. doi:10.1001/jama.2013.13805

Mokdad AA, Lopez AD, Shahraz S, et al. (2014) Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 12:145. doi:10.1186/s12916-014-0145-y PubMedCentralPubMed

Pinzani M, Rombouts K (2004) Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36:231–242. doi:10.1016/j.dld.2004.01.003 PubMed

Schölmerich J, Holstege A (1990) Aetiology and pathophysiology of chronic liver disorders. Drugs 40(Suppl 3):3–22PubMed

Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA (2014) Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 14:181–194. doi:10.1038/nri3623 PubMed

Bedossa P, Poynard T, The METAVIR Cooperative Study Group (1996) An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24:289–293. doi:10.1002/hep.510240201 PubMed

The French METAVIR Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20:15–20

Ishak K, Baptista A, Bianchi L, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699PubMed

10.

Mannan R, Misra V, Misra SP, Singh PA, Dwivedi M (2014) A comparative evaluation of scoring systems for assessing necro-inflammatory activity and fibrosis in liver biopsies of patients with chronic viral hepatitis. 10.7860/JCDR/2014/8704.4718 8:FC08–FC12

11.

Actis GC, Olivero A, Lagget M, et al. (2007) The practice of percutaneous liver biopsy in a gastrohepatology day hospital: a retrospective study on 835 biopsies. Dig Dis Sci 52:2576–2579. doi:10.1007/s10620-006-9724-x PubMed

12.

Cadranel JF, Rufat P, Degos F (2000) Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32:477–481. doi:10.1053/jhep.2000.16602 PubMed

13.

van der Poorten D, Kwok A, Lam T, et al. (2006) Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J 36:692–699. doi:10.1111/j.1445-5994.2006.01216.x PubMed

14.

Sparchez Z (2005) Complications after percutaneous liver biopsy in diffuse hepatopathies. Rom J Gastroenterol 14:379–384PubMed

15.

Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500. doi:10.1056/NEJM200102153440706 PubMed

16.

Rousselet M-C, Michalak S, Dupré F, et al. (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41:257–264. doi:10.1002/hep.20535 PubMed

17.

Regev A, Berho M, Jeffers LJ, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618. doi:10.1111/j.1572-0241.2002.06038.x PubMed

18.

Bedossa P, Dargère D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449–1457. doi:10.1016/j.hep.2003.09.022 PubMed

19.

Imbert-Bismut F, Ratziu V, Pieroni L, et al. (2001) Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357:1069–1075. doi:10.1016/S0140-6736(00)04258-6 PubMed

20.

Wai C-T, Greenson JK, Fontana RJ, et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518–526. doi:10.1053/jhep.2003.50346 PubMed

21.

Rosenberg WMC, Voelker M, Thiel R, et al. (2004) Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127:1704–1713PubMed

22.

Crespo G, Fernandez-Varo G, Marino Z, et al. (2012) ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. J Hepatol 57:281–287. doi:10.1016/j.jhep.2012.03.016 PubMed

23.

Forns X, Ampurdanès S, Llovet JM, et al. (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36:986–992. doi:10.1053/jhep.2002.36128 PubMed

24.

Adams LA, Bulsara M, Rossi E, et al. (2005) Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51:1867–1873. doi:10.1373/clinchem.2005.048389 PubMed

25.

Cales P, Oberti F, Michalak S, et al. (2005) A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42:1373–1381. doi:10.1002/hep.20935 PubMed

26.

Sterling RK, Lissen E, Clumeck N et al. (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43:1317–1325. doi: 10.1002/hep.21178

27.

Wang Q-B, Zhu H, Liu H-L, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56:239–247. doi:10.1002/hep.25610 PubMed

28.

Chak E, Talal AH, Sherman KE, Schiff ER (2011) Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 31:1090–1101. doi:10.1111/j.1478-3231.2011.02494.x PubMed

29.

Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57:1333–1342. doi:10.1002/hep.26141 PubMed

30.

Corey KE, Mendez-Navarro J, Gorospe EC, Zheng H, Chung RT (2010) Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis. J Viral Hepat 17:201–207. doi:10.1111/j.1365-2893.2009.01167.x PubMedCentralPubMed

31.

Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132:296–305

32.

Rosen HR (2011) Clinical practice. Chronic hepatitis C infection. N Engl J Med 364:2429–2438. doi:10.1056/NEJMcp1006613 PubMed

33.

Thein H-H, Yi Q, Dore GJ, Krahn MD (2008) Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 48:418–431. doi:10.1002/hep.22375 PubMed

34.

Poynard T, Bedossa P, Opolon P, The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349:825–832PubMed

35.

Brennan T, Shrank W (2014) New expensive treatments for hepatitis C infection. JAMA 312:593–594. doi:10.1001/jama.2014.8897 PubMed

36.

Wong GL-H (2014) Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol 20:228–236. doi:10.3350/cmh.2014.20.3.228 PubMedCentralPubMed

37.

Arena U, Vizzutti F, Abraldes JG, et al. (2008) Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 57:1288–1293. doi:10.1136/gut.2008.149708 PubMed

38.

Castera L, Vergniol J, Foucher J, et al. (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350PubMed

39.

Sporea I, Sirli R, Deleanu A, Popescu A, Cornianu M (2008) Liver stiffness measurement by transient elastography in clinical practice. J Gastrointestin Liver Dis 17:395–399PubMed

40.

Sporea I, Sirli R, Deleanu A, et al. (2008) Comparison of the liver stiffness measurement by transient elastography with the liver biopsy. World J Gastroenterol 14:6513–6517PubMedCentralPubMed

41.

Nitta Y, Kawabe N, Hashimoto S, et al. (2009) Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res 39:675–684. doi:10.1111/j.1872-034X.2009.00500.x PubMed

42.

Masuzaki R, Tateishi R, Yoshida H, et al. (2008) Comparison of liver biopsy and transient elastography based on clinical relevance. Canadian journal of gastroenterology =. J Can de Gastroenterologie 22:753–757

43.

Lupsor M, Badea R, Stefanescu H, et al. (2008) Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients. J Gastrointest Liver Dis 17:155–163

44.

Kim MY, Jeong WK, Baik SK (2014) Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 20:4300–4315. doi:10.3748/wjg.v20.i15.4300 PubMedCentralPubMed

45.

Sporea I, Sirli R, Bota S, et al. (2012) Comparative study concerning the value of acoustic radiation force impulse elastography (ARFI) in comparison with transient elastography (TE) for the assessment of liver fibrosis in patients with chronic hepatitis B and C. Ultrasound Med Biol 38:1310–1316. doi:10.1016/j.ultrasmedbio.2012.03.011 PubMed

46.

Rizzo L, Calvaruso V, Cacopardo B, et al. (2011) Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol 106:2112–2120. doi:10.1038/ajg.2011.341 PubMed

47.

Ferraioli G, Tinelli C, Dal Bello B et al. (2012) Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology 56:2125–2133. doi: 10.1002/hep.25936

48.

Samir AE, Dhyani M, Vij A, et al. (2014) Shear-Wave Elastography for the Estimation of Liver Fibrosis in Chronic Liver Disease: determining Accuracy and Ideal Site for Measurement. Radiology . doi:10.1148/radiol.14140839

49.

Sporea I, Bota S, Peck-Radosavljevic M, et al. (2012) Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol 81:4112–4118. doi:10.1016/j.ejrad.2012.08.018 PubMed

50.

Lupsor M, Badea R, Stefanescu H, et al. (2009) Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C Preliminary results. J Gastrointestin Liver Dis 18:303–310PubMed

51.

Canavan C, Eisenburg J, Meng L, Corey K, Hur C (2013) Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK. Dig Dis Sci 58:2691–2704. doi:10.1007/s10620-013-2705-y PubMedCentralPubMed

52.

Wright TL (2006) Introduction to chronic hepatitis B infection. Am J Gastroenterol 101(Suppl 1):S1–S6. doi:10.1111/j.1572-0241.2006.00469.x PubMed

53.

Branchi F, Conti CB, et al. (2014) Non-invasive assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 20:14568–14580. doi:10.3748/wjg.v20.i40.14568 PubMedCentralPubMed

54.

Park BK, Park YN, Ahn SH, et al. (2007) Long-term outcome of chronic hepatitis B based on histological grade and stage. J Gastroenterol Hepatol 22:383–388. doi:10.1111/j.1440-1746.2007.04857.x PubMed

55.

Oliveri F, Coco B, Ciccorossi P, et al. (2008) Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol 14:6154–6162PubMedCentralPubMed

56.

Maimone S, Calvaruso V, Pleguezuelo M, et al. (2009) An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers. J Viral Hepat 16:769–774. doi:10.1111/j.1365-2893.2009.01120.x PubMed

57.

Vigano M, Paggi S, Lampertico P, et al. (2011) Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation. Aliment Pharmacol Ther 34:353–362. doi:10.1111/j.1365-2036.2011.04722.x PubMed

58.

Cardoso A-C, Carvalho-Filho RJ, Stern C, et al. (2012) Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 32:612–621. doi:10.1111/j.1478-3231.2011.02660.x PubMed

59.

Verveer C, Zondervan PE, ten Kate FJW, Hansen BE, de Knegt RJ (2012) Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int 32:622–628. doi:10.1111/j.1478-3231.2011.02663.x PubMed

60.

Chan HL-Y, Wong GL-H, Choi PC-L, et al. (2009) Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 16:36–44. doi:10.1111/j.1365-2893.2008.01037.x PubMed

61.

Marcellin P, Ziol M, Bedossa P, et al. (2009) Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29:242–247. doi:10.1111/j.1478-3231.2008.01802.x PubMed

62.

Degos F, Perez P, Roche B, et al. (2010) Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 53:1013–1021. doi:10.1016/j.jhep.2010.05.035 PubMed

63.

Friedrich-Rust M, Buggisch P, de Knegt RJ, et al. (2013) Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B. J Viral Hepat 20:240–247. doi:10.1111/j.1365-2893.2012.01646.x PubMed

64.

Zhang D, Chen M, Wang R, et al. (2015) Comparison of Acoustic Radiation Force Impulse Imaging and Transient Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B. Ultrasound Med Biol 41:7–14. doi:10.1016/j.ultrasmedbio.2014.07.018 PubMed

65.

Chalasani N, Younossi Z, Lavine JE et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592–1609. doi: 10.1053/j.gastro.2012.04.001

66.

Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285. doi:10.1111/j.1365-2036.2011.04724.x PubMed

67.

Palmeri ML, Wang MH, Rouze NC, et al. (2011) Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 55:666–672. doi:10.1016/j.jhep.2010.12.019 PubMedCentralPubMed

68.

Motosugi U, Ichikawa T, Niitsuma Y, Araki T (2011) Acoustic radiation force impulse elastography of the liver: can fat deposition in the liver affect the measurement of liver stiffness? Jpn J Radiol 29:639–643. doi:10.1007/s11604-011-0607-5 PubMed

69.

Ebinuma H, Saito H, Komuta M, et al. (2011) Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan((R)). J Gastroenterol 46:1238–1248. doi:10.1007/s00535-011-0437-3 PubMed

70.

Bota S, Sporea I, Sirli R, Popescu A, Jurchis A (2013) Factors which influence the accuracy of acoustic radiation force impulse (ARFI) elastography for the diagnosis of liver fibrosis in patients with chronic hepatitis C. Ultrasound Med Biol. doi: 10.1016/j.ultrasmedbio.2012.09.017. (null:407–412)

71.

Poynard T, Munteanu M, Luckina E, et al. (2013) Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. J Hepatol 58:928–935. doi:10.1016/j.jhep.2012.12.021 PubMed

72.

Chen S-H, Li Y-F, Lai H-C, et al. (2012) Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C. BMC Gastroenterology 12:105. doi:10.1186/1471-230X-12-105 PubMedCentralPubMed

73.

Yoon KT, Lim SM, Park JY, et al. (2012) Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. Dig Dis Sci 57:1682–1691. doi:10.1007/s10620-012-2044-4 PubMed

74.

Guzmán-Aroca F, Frutos-Bernal MD, Bas A et al. (2012) Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. Eur Radiol 22:2525–2532. doi: 10.1007/s00330-012-2505-3

75.

Bota S, Sporea I, Peck-Radosavljevic M, et al. (2013) The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. Dig Liver Dis 45:762–768. doi:10.1016/j.dld.2013.02.008 PubMed

76.

Fierbinteanu-Braticevici C, Sporea I, Panaitescu E, Tribus L (2013) Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. Ultrasound Med Biol 39:1942–1950. doi:10.1016/j.ultrasmedbio.2013.04.019 PubMed

77.

Takaki S, Kawakami Y, Miyaki D, et al. (2014) Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients. Hepatol Res 44:280–287. doi:10.1111/hepr.12129 PubMed

78.

Yoneda M, Mawatari H, Fujita K, et al. (2008) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 40:371–378. doi:10.1016/j.dld.2007.10.019 PubMed

79.

Wong VW-S, Vergniol J, Wong GL-H, et al. (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454–462. doi:10.1002/hep.23312 PubMed

80.

Lupsor M, Badea R, Stefanescu H, et al. (2010) Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis 19:53–60PubMed

81.

Petta S, Di Marco V, Camma C, et al. (2011) Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 33:1350–1360. doi:10.1111/j.1365-2036.2011.04668.x PubMed

82.

Wong VW-S, Vergniol J, Wong GL-H, et al. (2012) Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 107:1862–1871. doi:10.1038/ajg.2012.331 PubMed

83.

Myers RP, Pomier-Layrargues G, Kirsch R, et al. (2012) Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55:199–208. doi:10.1002/hep.24624 PubMed

84.

Yoneda M, Suzuki K, Kato S, et al. (2010) Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography 1. Radiology 256:640–647. doi:10.1148/radiol.10091662 PubMed

85.

Yoshioka K, Hashimoto S, Kawabe N (2014) Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease. Hepatol Res . doi:10.1111/hepr.12388

86.

Hoyert DL, Xu J (2012) Deaths: preliminary data for 2011. Natl Vital Stat Rep 61:1–51PubMed

87.

Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572–1585. doi:10.1053/j.gastro.2011.09.002 PubMedCentralPubMed

88.

Nahon P, Kettaneh A, Tengher-Barna I, et al. (2008) Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 49:1062–1068. doi:10.1016/j.jhep.2008.08.011 PubMed

89.

Nguyen-Khac E, Chatelain D, Tramier B, et al. (2008) Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 28:1188–1198. doi:10.1111/j.1365-2036.2008.03831.x PubMed

90.

Zhang D, Li P, Chen M, et al. (2014) Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease using acoustic radiation force impulse elastography. Abdom Imaging . doi:10.1007/s00261-014-0154-5

91.

Bardou-Jacquet E, Legros L, Soro D, et al. (2013) Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol 19:516–522. doi:10.3748/wjg.v19.i4.516 PubMedCentralPubMed

92.

Al-Harthy N, Kumagi T (2012) Natural history and management of primary biliary cirrhosis. Hepat Med 4:61–71. doi:10.2147/HMER.S25998 PubMedCentralPubMed

93.

Corpechot C, El Naggar A, Poujol-Robert A, et al. (2006) Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43:1118–1124. doi:10.1002/hep.21151 PubMed

94.

Zhang D-K, Chen M, Liu Y, et al. (2014) Acoustic radiation force impulse elastography for non-invasive assessment of disease stage in patients with primary biliary cirrhosis: a preliminary study. Clin Radiol 69:836–840. doi:10.1016/j.crad.2014.03.019 PubMed

95.

Whiting-O’Keefe QE, Fye KH, Sack KD (1991) Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 90:711–716PubMed

96.

Bambha K, Kim WR, Talwalkar J, et al. (2003) Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125:1364–1369PubMed

97.

Corpechot C, Gaouar F, El Naggar A, et al. (2014) Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology 146:970–979 ((quiz e15–e16)). doi:10.1053/j.gastro.2013.12.030 PubMed

98.

Ehlken H, Lohse AW, Schramm C (2014) Transient elastography in primary sclerosing cholangitis-the value as a prognostic factor and limitations. Gastroenterology 147:542–543. doi:10.1053/j.gastro.2014.04.058 PubMed

99.

Righi S, Fiorini E, De Molo C, et al. (2012) ARFI elastography in patients with chronic autoimmune liver diseases: a preliminary study. J Ultrasound 15:226–231PubMedCentralPubMed

100.

Romanque P, Stickel F, Dufour J-F (2008) Disproportionally high results of transient elastography in patients with autoimmune hepatitis. Liver Int 28:1177–1178. doi:10.1111/j.1478-3231.2008.01743.x PubMed

101.

Colli A, Fraquelli M, Casazza G, et al. (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 101:513–523. doi:10.1111/j.1572-0241.2006.00467.x PubMed

102.

Ma X, Zhan W, Zhang B, et al. (2014) Elastography for the differentiation of benign and malignant liver lesions: a meta-analysis. Tumour Biol 35:4489–4497. doi:10.1007/s13277-013-1591-4 PubMed

103.

Cho SH, Lee JY, Han JK, Choi BI (2010) Acoustic radiation force impulse elastography for the evaluation of focal solid hepatic lesions: preliminary findings. Ultrasound Med Biol 36:202–208. doi:10.1016/j.ultrasmedbio.2009.10.009 PubMed

104.

Heide R, Strobel D, Bernatik T, Goertz RS (2010) Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry. Ultraschall Med 31:405–409. doi:10.1055/s-0029-1245565 PubMed

105.

Park H, Park JY, Kim DY, et al. (2013) Characterization of focal liver masses using acoustic radiation force impulse elastography. World J Gastroenterol 19:219–226. doi:10.3748/wjg.v19.i2.219 PubMedCentralPubMed

106.

Ronot M, Di Renzo S, Gregoli B, et al. (2014) Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography. Eur Radiol . doi:10.1007/s00330-014-3370-z

107.

Guibal A, Boularan C, Bruce M, et al. (2013) Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound. Eur Radiol 23:1138–1149. doi:10.1007/s00330-012-2692-y PubMed

108.

Davies G, Koenen M (2011) Acoustic radiation force impulse elastography in distinguishing hepatic haemangiomata from metastases: preliminary observations. Br J Radiol 84:939–943. doi:10.1259/bjr/97637841 PubMedCentralPubMed

109.

Gallotti A, D’Onofrio M, Romanini L, Cantisani V, Pozzi Mucelli R (2012) Acoustic Radiation Force Impulse (ARFI) ultrasound imaging of solid focal liver lesions. Eur J Radiol 81:451–455. doi:10.1016/j.ejrad.2010.12.071 PubMed

110.

Kim JE, Lee JY, Bae KS, Han JK, Choi BI (2013) Acoustic radiation force impulse elastography for focal hepatic tumors: usefulness for differentiating hemangiomas from malignant tumors. Korean J Radiol 14:743–753. doi:10.3348/kjr.2013.14.5.743 PubMedCentralPubMed

111.

Zhang P, Zhou P, Tian S-M, et al. (2013) Application of acoustic radiation force impulse imaging for the evaluation of focal liver lesion elasticity. Hepatobiliary Pancreat Dis Int 12:165–170PubMed

112.

Yu H, Wilson SR (2011) Differentiation of benign from malignant liver masses with acoustic radiation force impulse technique. Ultrasound Q 27:217–223. doi:10.1097/RUQ.0b013e318239422e PubMed

113.

Merkel C, Montagnese S (2011) Hepatic venous pressure gradient measurement in clinical hepatology. Dig Liver Dis 43:762–767. doi:10.1016/j.dld.2011.03.002 PubMed

114.

Asrani SK, Kamath PS (2013) Natural history of cirrhosis. Curr Gastroenterol Rep 15:308. doi:10.1007/s11894-012-0308-y PubMed

115.

Albilllos A, Garcia-Tsao G (2011) Classification of cirrhosis: the clinical use of HVPG measurements. Dis Markers 31:121–128. doi:10.3233/DMA-2011-0834 PubMedCentralPubMed

116.

D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231. doi:10.1016/j.jhep.2005.10.013 PubMed

117.

de Franchis R (2005) Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol 43:167–176

118.

Garcia-Tsao G, Friedman S, Iredale J, Pinzani M (2010) Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 51:1445–1449. doi:10.1002/hep.23478 PubMedCentralPubMed

119.

Ripoll C, Groszmann R, Garcia-Tsao G, et al. (2007) Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133:481–488. doi:10.1053/j.gastro.2007.05.024 PubMed

120.

Shi K-Q, Fan Y-C, Pan Z-Z, et al. (2013) Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int 33:62–71. doi:10.1111/liv.12003 PubMed

121.

Elkrief L, Rautou P-E, Ronot M, et al. (2014) Prospective comparison of Spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology . doi:10.1148/radiol.14141210 PubMed

Title: Ultrasound elastography: liver
Authors: Manish Dhyani
Arash Anvari
Anthony E. Samir
Publication date: 01-04-2015
Publisher: Springer US
Published in: Abdominal Radiology / Issue 4/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-015-0373-4

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

Primary cystic peritoneal masses and mimickers: spectrum of diseases with pathologic correlation

Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography

Inter- and intra-individual comparative study of two gadolinium-based agents: A pilot study

Acoustic radiation force impulse quantification of spleen elasticity for assessing liver fibrosis

Frequency, CT findings, and fate of multiple infarcted regenerative nodules in liver cirrhosis after variceal bleeding or septic shock

Magnetic Resonance Elastography of Liver: Influence of Intravenous Gadolinium Administration on Measured Liver Stiffness

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage